NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00248287 2025-01-29CA225200US Oncology ResearchPhase 2 Active not recruiting154 enrolled 12 charts